Clinical trialNCT06561048RecruitingPhase 3Interventional

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

SponsorCorvus Pharmaceuticals, Inc.Enrollment150Angioimmunoblastic T-cell LymphomaFollicular T-Cell LymphomaLymphoma, T-CellLymphoma, T-Cell, PeripheralNodal Peripheral T-Cell Lymphoma With TFH PhenotypePeripheral T-Cell Lymphoma, Not Otherwise Specified+1 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas (FHTCLs), or systemic anaplastic large-cell lymphoma (sALCL).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Suresh Mahabhashyam, MD, MPH
Corvus Pharmaceuticals, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

St Vincent'S Hospital Sydney
Darlinghurst, New South Wales, Australia
Orly Lavee
Recruiting
St George Hospital
Kogarah, New South Wales, Australia
Recruiting
Icon Cancer Centre
South Brisbane, Queensland, Australia
Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Pratyush Giri
Recruiting
Flinders Medical Center
Bedford Park, South Australia, Australia
Kate Manos
Recruiting
Royal Hobart Hospital
Hobart, Tasmania, Australia
Anna Johnston
Recruiting
Box Hill Hospital
Box Hill, Victoria, Australia
Tamara Marconi
Recruiting
Austin Hospital
Heidelberg, Victoria, Australia
Eliza Hawkes
Recruiting
Epworth Healthcare
Richmond, Victoria, Australia
Recruiting
Linear Clinical Research
Perth, Western Australia, Australia
Dejan Radeski, MBBS
Recruiting

Canada

Bc Cancer Research Institute
Vancouver, British Columbia, Canada
Recruiting
the Ottawa Hospital - General Campus
Ottawa, Ontario, Canada
Recruiting
the Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Anca Prica
Recruiting

United States

City of Hope National Medical Center
Duarte, California, United States
Christina Poh, MD
Recruiting
University of California, Irvine
Irvine, California, United States
Recruiting
University of California San Francisco
San Francisco, California, United States
Weiyun Ai, MD
Recruiting
Yale University
New Haven, Connecticut, United States
Francine Foss, MD
Recruiting
Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine
Miami, Florida, United States
Recruiting
Emory University
Atlanta, Georgia, United States
Recruiting
North Western University Robert H. Lurie Comprehensive Cancer Center Rhlccc
Chicago, Illinois, United States
Jonathan Moreira, MD
Recruiting
University of Iowa
Iowa City, Iowa, United States
Eric Mou, MD
Recruiting
University of Maryland Medical Center
Baltimore, Maryland, United States
Kathryn Kline, MD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Salvia Jain, MD
Recruiting
Roger Cancer Center University of Michigan Health
Ann Arbor, Michigan, United States
Ryan Wilcox, MD
Recruiting
Washington University in St. Louis
St Louis, Missouri, United States
Neha Mehta-Shah, MD
Recruiting
Hackensack University Medical Center
Hackensack, New Jersey, United States
Tatyana Feldman, MD
Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Roshan Asrani, MD
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Jasmine Zain, MD
Recruiting
Weill Cornell Medicine
New York, New York, United States
Jia Ruan, MD, PHD
Recruiting
North Carolina Cancer Hospital
Chapel Hill, North Carolina, United States
Anne Beaven, MD
Recruiting
the Ohio State University
Columbus, Ohio, United States
John Reneau, MD, PHD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Swaminathan Iyer, MD
Recruiting
University of Washington Fred Hutch Cancer Center
Seattle, Washington, United States
Stephen Smith, MD
Recruiting
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Belinostat →PralatrexateSoquelitinib

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Oct 2024
Primary completion: 30 Nov 2027
Completion: 31 Dec 2028
Last update posted: 8 Apr 2026
Registered enrollment: 150
Registry id: NCT06561048

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.